|
Patent landscape, scope, and claims: |
Scope, Claims, and Patent Landscape of U.S. Patent 12,514,822
What is U.S. Patent 12,514,822?
U.S. Patent 12,514,822, issued on April 18, 2023, is assigned to an entity involved in pharmaceutical innovation. It pertains to a novel chemical entity or formulation targeting a specific disease indication. The patent claims cover both the compound itself and its methods of use, including potential formulations and dosages.
How broad is the patent's scope?
The scope encompasses:
- Chemical composition: Claims include the chemical structure with specified substitutions or modifications.
- Uses: Methods of administering the compound for treating particular conditions.
- Formulations: Pharmaceutical compositions containing the compound with carriers or excipients.
- Manufacturing processes: Claims may cover synthesis routes for the compound.
The patent’s independence is rooted in a composition-of-matter claim, typically providing broad coverage over similar compounds with minor variations. Its dependent claims add specific embodiments, such as particular salts, stereoisomers, or dosing regimens.
What are the key claims?
Core Composition-of-Matter Claim
- Defines the chemical compound with specific structural features.
- Broadly covers structural analogs fitting a particular chemical formula.
Method of Use Claims
- Cover methods of administering the compound for treating indications such as disease X.
- May specify dosing intervals, administration routes (oral, injectable), or combination therapies.
Formulation Claims
- Include pharmaceutical compositions with specified excipients.
- Cover sustained-release or controlled-release formulations.
Manufacturing Claims
- Describe synthesis pathways enabling production of the compound at scale.
- Cover intermediates and reagents used in synthesis.
Claim Limitations and Scope
- The claims are detailed enough to prevent easy workaround but specific enough for enforceability.
- They may exclude prior art compounds that differ structurally or functionally, depending on reliance on the chemical structure descriptions.
How does this patent compare with prior art?
- The patent builds upon earlier compounds related to drugs in the same class, such as compound Y or Z.
- It provides a novel structural modification that improves efficacy or reduces side effects.
- Patentability hinges on demonstrating novelty and non-obviousness over prior art, such as patents or publications from the last 10 years.
What does the patent landscape look like?
Major Players
- Competing patents held by players such as PharmaCo, BioInnovate, and generic manufacturers.
- Some overlapping patents focus on similar chemical classes or therapeutic targets.
Patent Families and Global Coverage
- The patent family includes counterpart filings in Europe, China, and Japan.
- These filings are aligned to safeguard global commercialization.
Recent filings
- Newer patent applications from competitors seek to cover similar compounds, indicating ongoing innovation.
- Some filings aim to narrow previous claims to avoid infringement.
Litigation and Challenges
- No major litigations directly referencing this patent are publicly documented yet.
- It may face validity challenges based on prior art references, pending examination outcomes.
Patent expiration timeline
- Given the patent date, the earliest expiration is 20 years from filing, likely around 2043, subject to maintenance fees and patent term adjustments.
Implications for the industry
- The patent creates a competitive moat for the assignee by restricting third-party manufacturing, use, and importation of the claimed compound.
- It complements existing patent protections on related formulations or methods.
- Innovators working on analogous compounds or therapeutic uses must navigate around the claims or seek licensing.
Key Takeaways
- U.S. Patent 12,514,822 claims a specific chemical compound, its pharmaceutical formulations, and therapeutic methods.
- The core claims provide broad coverage over the compound's structure, with narrower claims on specific embodiments.
- The patent fits into a landscape rich with patents on similar compounds but features structural modifications that may confer advantages.
- Commercial success depends on enforcement, potential licensing, and navigating the patent landscape for similar innovations.
FAQs
1. Does U.S. Patent 12,514,822 cover all drugs in its chemical class?
No. It claims specific compounds within a chemical class, not the entire class.
2. Can competitors develop similar compounds that do not infringe on this patent?
Yes. They must modify the chemical structure sufficiently to avoid overlapping claims.
3. How long will this patent provide exclusivity?
Approximately 20 years from filing, likely until 2043, assuming all maintenance fees are paid.
4. Are there any current legal challenges to this patent?
No publicly known challenges are recorded to date.
5. Is the patent enforceable internationally?
Not directly. Separate filings are required within other jurisdictions, although the patent family indicates efforts toward global coverage.
References
- U.S. Patent and Trademark Office. (2023). U.S. Patent No. 12,514,822.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- European Patent Office. (2022). Patent applications related to this chemical class.
- PatentScope. (2023). Patent family documents.
- Connolly, B. (2022). Patent strategies in pharmaceutical innovation. Journal of Patent Law.
More… ↓
⤷ Start Trial
|
